Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MYC | P01106 | 3/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.31 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.31 |
| ▸ | MAX | P61244 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30520996 | 1.00 | MEN1 (0.36) | MEN1KMT2AIDO1TDO2GLA | |
| SCHEMBL25342114 | 0.92 | MYC (0.35) | MEN1KMT2AIDO1TDO2HTT | |
| SCHEMBL30520833 | 0.92 | MYC (0.35) | MEN1KMT2AIDO1TDO2HTT | |
| SCHEMBL30521124 | 0.88 | MYC (0.38) | MEN1KMT2AMYCDPP4DPP8 | |
| SCHEMBL25342711 | 0.88 | MYC (0.38) | MEN1KMT2AMYCDPP4DPP8 | |
| SCHEMBL25339888 | 0.87 | MYC (0.33) | MEN1KMT2AIDO1TDO2MYC | |
| SCHEMBL30521037 | 0.87 | MYC (0.33) | MEN1KMT2AIDO1TDO2MYC | |
| SCHEMBL25345199 | 0.84 | GSTP1 (0.34) | MEN1KMT2AHTTMYCMAX | |
| SCHEMBL30521540 | 0.84 | GSTP1 (0.34) | MEN1KMT2AHTTMYCMAX | |
| SCHEMBL25342557 | 0.84 | IDO1 (0.34) | MEN1KMT2AIDO1TDO2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023143494-A1 | NEW PROTAC COMPOUND | 甘李药业股份有限公司 | 2023-08-03 | — | — | WO | disclosed |